Insulet Corporation (NASDAQ: PODD) kicked off on Friday, up 1.27% from the previous trading day, before settling in for the closing price of $190.88. Over the past 52 weeks, PODD has traded in a range of $125.82-$283.07.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 24.75%. While this was happening, its average annual earnings per share was recorded 5.36%. With a float of $69.40 million, this company’s outstanding shares have now reached $69.91 million.
The extent of productivity of a business whose workforce counts for 3000 workers is very important to gauge.
Insulet Corporation (PODD) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Insulet Corporation is 0.91%, while institutional ownership is 101.51%. The most recent insider transaction that took place on Jun 14 ’24, was worth 299,940. In this transaction SVP & Chief Technology Officer of this company sold 1,500 shares at a rate of $199.96, taking the stock ownership to the 12,875 shares. Before that another transaction happened on Jun 10 ’24, when Company’s Director sold 7,000 for $190.51, making the entire transaction worth $1,333,570. This insider now owns 35,586 shares in total.
Insulet Corporation (PODD) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 5.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.90% during the next five years compared to 122.47% growth over the previous five years of trading.
Insulet Corporation (NASDAQ: PODD) Trading Performance Indicators
Take a look at Insulet Corporation’s (PODD) current performance indicators. Last quarter, stock had a quick ratio of 2.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.60. Likewise, its price to free cash flow for the trailing twelve months is 93.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.31, a number that is poised to hit 0.56 in the next quarter and is forecasted to reach 3.75 in one year’s time.
Technical Analysis of Insulet Corporation (PODD)
The latest stats from [Insulet Corporation, PODD] show that its last 5-days average volume of 0.73 million was inferior to 0.84 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 24.76%. Additionally, its Average True Range was 7.68.
During the past 100 days, Insulet Corporation’s (PODD) raw stochastic average was set at 67.35%, which indicates a significant increase from 44.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 23.70% in the past 14 days, which was lower than the 37.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $192.84, while its 200-day Moving Average is $181.83. Now, the first resistance to watch is $200.87. This is followed by the second major resistance level at $208.44. The third major resistance level sits at $218.65. If the price goes on to break the first support level at $183.09, it is likely to go to the next support level at $172.88. Assuming the price breaks the second support level, the third support level stands at $165.31.
Insulet Corporation (NASDAQ: PODD) Key Stats
The company with the Market Capitalisation of 13.54 billion has total of 70,040K Shares Outstanding. Its annual sales at the moment are 1,697 M in contrast with the sum of 206,300 K annual income. Company’s last quarter sales were recorded 441,700 K and last quarter income was 51,500 K.
